The role of systemic lidocaine in neuropathic pain management

Journal of Intravenous Nursing

Volumn 22, Issue 5, 1999, Pages 273-279

  Edwards, Annabel D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE;

BURN; CANCER PAIN; DIABETES MELLITUS; HUMAN; LOCAL ANESTHESIA; PAIN; POSTHERPETIC NEURALGIA; REVIEW; STROKE; TREATMENT INDICATION;

ANESTHETICS, LOCAL; DRUG INTERACTIONS; EVIDENCE-BASED MEDICINE; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; LIDOCAINE; NEURALGIA; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 0033499580     PISSN: 08965846     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Bonica JJ. Anatomic and physiologic basis of nociception and pain. In: Bonica JJ, ed. The Management of Pain. 2nd ed. Philadelphia: Lea & Febiger, 1990:28-94.
2. Fields HL. Pain. New York: McGraw-Hill Book Co., 1987.
3. Janig W. Pathophysiology of nerve following mechanical injury in man. In: Dubner R, Gebhart GF, Bond MR, eds. Pain research and clinical management. Amsterdam: Elsevier, 1988;3:89-108.
4. Wall PD. Neuropathic pain and injured nerves: central mechanisms. Br Med Bull 1991;47:631-43.
5. Woolf CJ, Shortland P, Coggeshall RE. Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 1992;355: 75-8.
6. Bowsher D. Neurogenic pain syndromes and their management. Br Med Bull 1991;47:644-66.
7. Devor M. Nerve pathophysiology and mechanisms of pain in causalgia. J Auton Nerv Syst 1983;7:371-84.
8. Devor M. Neuropathic pain and injured nerve: peripheral mechanisms. Br Med Bull 1991;47:619-30.
9. Devor M. The pathophysiology of damaged nerves. In: Wall PD, Melzak R, eds. Textbook of Pain. Oxford: Churchill-Livingston, 1989: 63-81.
10. Devor M, Govrin-Lippmann R. Axoplasmic transport block reduces ectopic impulse generation in injured peripheral nerves. Pain 1983;16:73-85.
11. Devor M, Wall PD, Catalan N. Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 1992;48:261-8.
12. Ferrante FM, Paggioli J, Cherukuri S, Arthur GR. The analgesic response to intravenous lidocaine in the treatment of neuropathic pain. Anesth Analg 1996;82:91-7.
13. Galer BS, Miller KV, Rowbotham, MC. Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury. Neurology 1993;43:1233-5.
14. Swerdlow M. Review: the use of local anesthetics for relief of chronic pain. The Pain Clinic 1988;2:3-6.
15. Tanelian DL, Brose WG. Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine. Anesthesiology 1991;74:949-51.
16. Wallace MS, Dyck JB, Rossi SS, Yaksh TL. Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain 1996;66:69-77.
17. Catterall W, Mackie K. Local anesthetics. In: Goodman, & Gilman's. The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw-Hill, 1996:331-48.
18. Covino B. Clinical pharmacology of local anesthetic agents. In: Cousins M, Bridenbaugh, P, eds. Neural Blockade in Clinical Anesthesia and Management of Pain. 2nd ed. Philadelphia: JB Lippincott, 1988:111-44.
19. Hondeghem L, Roden D. Agents used in cardiac arrhythmias. In: Katzung B, ed. Basics & Clinical Pharmacology. 6th ed. Norwalk: Appleton & Lange, 1995:205-29.
20. Loebl S, Spratto G, Heckheimer E. The Nurse's Drug Handbook. 3rd ed. New York: John Wiley & Sons, 1983:445-7, 654-60.
21. Miller R, Hondeghem L. Local anesthetics. In: Katzung B, ed. Basics & Clinical Pharmacology. 6th ed. Norwalk: Appleton & Lange, 1995:395-403.
22. Brose WG, Cousins MJ. Subcutaneous lidocaine for treatment of neuropathic cancer pain. Pain 1991;45:145-8.
23. Devulder JE, Ghys L, Dhondt W, Rolly G. Neuropathic pain in a cancer patient responding to subcutaneously administered lignocaine. The Clinical Journal of Pain 1993;9(3):220-3.
24. Wallace MS, Lee J, Sorkin L, Dunn JS, Yaksh T, Yu A. Intravenous lidocaine: effects on controlling pain after anti-GD2 antibody therapy in children with neuroblastoma. A report of a series. Anesth Analg 1997;85:794-6.
25. Bruera E, Ripamonti C, Brenneis C, Macmillan K, Hanson J. A randomized double-blind crossover trial of intravenous lidocaine in the treatment of neuropathic cancer pain. Journal of Pain and Symptom Management 1992;7(3):138-40.
26. Backonja M, Gombar K. Response of central pain syndromes to intravenous lidocaine. Journal of Pain and Symptom Management 1992;7(3):172-8.
27. Edmondson EA, Simpson RK, Strubler DK, Beric A. Systemic lidocaine therapy for poststroke pain. South Med J 1993;86:1093-6.
28. Dixon CL, Berger JJ. Poster: intravenous lidocaine in the treatment of postherpetic neuralgia. Regional Anesthesia 1992;17(1Suppl):61.
29. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991;41:1024-8.
30. Kastrup J, Petersen P, Dejgard A, Angelo HR, Hilsted J. Intravenous lidocaine infusion: a new treatment of chronic painful diabetic neuropathy? Pain 1987;28:69-75.
31. Marchettini P, Lacerenza M, Marangoni C, Pellegata G, Sotgiu ML, Smirne S. Lidocaine test in neuralgia. Pain 1992;48:377-82.
32. Jonsson A, Cassuto J, Hanson B. Inhibition of burn pain by intravenous lignocaine infusion. Lancet 1991;338:151-2.
33. Koch F, Huggins K. Perioperative care of environmentally sensitive patients. AORN Journal 1998;68:375-7, 379.